Michael C. Gundry
Broad Institute(US)Boston Children's Hospital(US)Howard Hughes Medical Institute(US)Harvard University(US)Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
CRISPR and Genetic Engineering, Acute Myeloid Leukemia Research, Epigenetics and DNA Methylation, CAR-T cell therapy research, Protein Degradation and Inhibitors
Most-Cited Works
- → Mutant NPM1 Maintains the Leukemic State through HOX Expression(2018)309 cited
- → Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9(2016)277 cited
- → Targeted DNA methylation in vivo using an engineered dCas9-MQ1 fusion protein(2017)218 cited
- → DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A(2017)208 cited
- → DNMT3A in Leukemia(2016)192 cited
- → Direct mutation analysis by high-throughput sequencing: From germline to low-abundant, somatic variants(2011)88 cited